CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial

Autor: Stebbing, Justin, Baranau, Yauheni, Baryash, Valeriy, Manikhas, Alexey, Moiseyenko, Vladimir, Dzagnidze, Giorgi, Zhavrid, Edvard, Boliukh, Dmytro, Stroyakovskii, Daniil, Pikiel, Joanna, Eniu, Alexandru, Komov, Dmitry, Morar-Bolba, Gabriela, Li, Rubi K, Rusyn, Andriy, Lee, Sang Joon, Lee, Sung Young, Esteva, Francisco J
Zdroj: In The Lancet Oncology July 2017 18(7):917-928
Databáze: ScienceDirect